Role of flavonoids against adriamycin toxicity
- 1 December 2020
- journal article
- review article
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 146, 111820
Abstract
No abstract availableKeywords
This publication has 173 references indexed in Scilit:
- Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitroToxicology, 2012
- Potential anti-inflammatory, anti-adhesive, anti/estrogenic, and angiotensin-converting enzyme inhibitory activities of anthocyanins and their gut metabolitesGenes & Nutrition, 2012
- Doxorubicin pathwaysPharmacogenetics and Genomics, 2011
- Baicalein protects against doxorubicin-induced cardiotoxicity by attenuation of mitochondrial oxidant injury and JNK activationJournal of Cellular Biochemistry, 2011
- Selected Dietary Flavonoids Are Associated with Markers of Inflammation and Endothelial Dysfunction in U.S. Women,The Journal of Nutrition, 2011
- Combined effects of p-coumaric acid and naringenin against doxorubicin-induced cardiotoxicity in ratsPharmacognosy Research, 2011
- New advances in molecular mechanisms and the prevention of adriamycin toxicity by antioxidant nutrientsFood and Chemical Toxicology, 2010
- Kaempferol modulates pro-inflammatory NF-κB activation by suppressing advanced glycation endproducts-induced NADPH oxidaseAGE, 2010
- Doxorubicin CardiomyopathyCardiology, 2009
- Baicalein inhibits IL-1β- and TNF-α-induced inflammatory cytokine production from human mast cells via regulation of the NF-κB pathwayClinical and Molecular Allergy, 2007